- Comprar cripto
- Mercados
- Futuros
- Spot
- Copy trading
WE-Launch
Bloomberg: Arthur Hayes has recently made a significant investment in a human longevity extension company and has been receiving regular intravenous stem cell infusion therapy over the past year.
BlockBeats News, August 21st. According to Bloomberg, BitMEX co-founder Arthur Hayes is shifting his investment focus to the field of human life extension. He recently made a significant investment in a stem cell company with clinics in Mexico and Bangkok, and has joined its board of directors. Over the past year, he has regularly flown to receive intravenous infusion treatments, stating that he "hopes to extend his life as healthily as possible." While the company's name was not disclosed due to ongoing rebranding, he emphasized: "This is a future trend - an increasing number of countries are relaxing regulations on stem cell usage."
También te puede interesar
Ganadores
Últimas noticias sobre criptomonedas
Deutsche Bank: If the next Fed Chair fails to effectively address inflation risks, the US Dollar may face downward pressure
Nine-Time Winning Trader Suffers First Defeat, Closing Out Short Position with Over $1.78 Million in Losses
The U.S. Money Market Asset Size Exceeds $8 Trillion for the First Time
「Bull Buddy」 is once again hyping up for a long position, with an average entry price of $31.97.
Kalshi has completed a $1 billion funding round at a $1.1 billion valuation
Atención al cliente：@weikecs
Cooperación empresarial：@weikecs
Trading cuantitativo y MM：[email protected]
Programa VIP：[email protected]
App